Abbott sales 18% fall due to anticipation of COVID testing sales declines
AstraZeneca confident new COVID antibody protects against known variants
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma
Is Pear’s demise a sign of things to come for digital therapeutics?
*please scroll down for all the latest news*
